A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
Clinical trial NCT07226895 · RECRUITING
Trial details
- NCT number
- NCT07226895
- Sponsor
- Monument Therapeutics Limited
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-03
- Primary completion
- 2027-09-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.